Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 181 results found. Search for [ Zydus coronavirus vaccine ]

Results 20 to 40 of 181
PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


BusinessToday.In
November 23, 2020
The Prime Minister is expected to hold two back-to-back meetings, one with those states with high caseloads and another related to vaccine distribution strategy.


BusinessToday.In
November 22, 2020
Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh


Joe C Mathew
November 21, 2020
\"We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also (to consider such an option),\" says Dr Vinod Paul, chairman of the National Expert Group on Vaccine Administration for COVID-19


BusinessToday.In
November 11, 2020
Coronavirus vaccine: India will focus on these two vaccines as they are being tested on the Indian population and hence has a major advantage over other potential candidates


Chitranjan Kumar
November 6, 2020
Cipla Q2 results: India business grew by 17 per cent YoY and 33 per cent QoQ on the back of strong growth across businesses and continued servicing of patients with COVID-19 portfolio


BusinessToday.In
November 3, 2020
German biotech firm CureVac has revealed its vaccine candidate has triggered an immune response during its phase 1 trials. The UK government has also started the process of the rolling review of AstraZeneca's candidate


BusinessToday.In
October 29, 2020
Coronavirus vaccine: PM Modi said that a digital platform is being created now that will eventually help in enrolling, tracking and reaching beneficiaries


BusinessToday.In
October 28, 2020
\"I've tested positive for COVID-19 and would request those who came in contact with me to get themselves tested at the earliest,\" Union minister Smriti Irani said in a tweet


Chitranjan Kumar
October 28, 2020
Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively


BusinessToday.In
October 28, 2020
ICMR in a tweet said, 'scientists at the council have found that the vaccine induces increased memory cell responses and total antibody production in the elderly'


BusinessToday.In
New Delhi, October 27, 2020
Sunil Mittal-led Bharti Airtel on Monday said it has entered the fast-growing cloud communications market with the launch of Airtel IQ today; Johnson & Johnson has said that the first batches of its COVID-19 vaccine could be available as soon as January; World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus on Sunday warned vaccine nationalism would only prolong the pandemic. Watch this and more on News Blast.Also Read: Ant Group IPO: 5 interesting facts about the world's biggest public offering


Vivek Punj
New Delhi, October 27, 2020
Johnson & Johnson says first batches of COVID-19 vaccine may be available as soon as JanuaryAmid ongoing coronavirus pandemic, Johnson & Johnson has said that the first batches of its COVID-19 vaccine could be available as soon as in January. The first batches of its shots are expected to be available for emergency use by starting 2021, Ruxandra Draghia-Akli, the company's head of public health research and development, said in a presentation at the World Health Summit.Bharti Airtel...


PB Jayakumar & Joe C Mathew
October 26, 2020
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020


BusinessToday.In
October 26, 2020
Coronavirus vaccine: The pharma company plans to start late-stage trials of the vaccine candidate next month. Over 26,000 candidates would be monitored for the vaccine candidate's efficacy


BusinessToday.In
October 23, 2020
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective


BusinessToday.In
October 22, 2020
Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials


BusinessToday.In
October 19, 2020
India Stock Market Highlights Today: ONGC, followed by NTPC, HDFC, Axis Bank, ICICI Bank, PowerGrid and Nestle India were among the top gainer on Sensex pack. On the other hand, TCS, Tech Mahindra, Infosys and Sun Pharma were among the laggards.


BusinessToday.In
October 19, 2020
Stocks to watch today on October 19: HDFC Bank, Tata Communications, Avenue Supermarts, Bajaj Consumer, RIL among others are the top stocks to watch out for in Monday's trading session


PAGES 2 OF 10  12345